On Wednesday, Shares of Verizon Communications Inc. (NYSE:VZ), lost -0.09% to $46.63.
Verizon declared this morning it will continue negotiations with the CWA and IBEW to reach agreements on new contracts covering more than 37,000 Wireline employees in the Northeast and Mid-Atlantic regions. The contracts expired at midnight, Aug. 1, 2015. Although new agreements have not been reached, no strike has been called and employees will continue to work as negotiations continue.
“We are disappointed that after six weeks of good faith bargaining and a very strong effort by the company, we have been unable to reach new agreements with the unions,” said Marc Reed, Verizon’s chief administrative officer. “Our employees will remain on the job serving the needs of our customers. In the meantime, we’ll continue to meet with union leadership with the aim of reaching agreements that are good for our customers and our employees and put Verizon’s Wireline unit on a path toward success in the years to come.”
Verizon Communications Inc., through its auxiliaries, provides communications, information, and entertainment products and services to consumers, businesses, and governmental agencies worldwide.
Shares of Violin Memory Inc (NYSE:VMEM), inclined 1.93% to $2.11, during its last trading session.
Violin Memory, declared that it will report financial results for its second quarter ended July 31, 2015, on Thursday, August 27, 2015. The results will be comprised of in a press release with accompanying financial information that will be released after U.S. markets close.
Violin Memory’s executive administration team will host a conference call starting at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) to talk about financial results and business highlights.
Violin Memory, Inc. develops and supplies memory-based storage systems to bring storage performance in line with high-speed applications, servers, and networks worldwide.
Finally, Zimmer Biomet Holdings Inc (NYSE:ZBH), ended its last trade with 0.73% gain, and closed at $103.88.
Zimmer Biomet Holdings stated financial results for the quarter ended June 30, 2015. The Company stated second quarter net sales of $1.17 billion, a decrease of 1.3% stated and an enhance of 5.7% constant currency contrast to the second quarter of 2014. Attained revenue from Biomet amounted to $60 million, a contribution of 5.0% of the constant currency growth rate. Standalone Zimmer recorded constant currency growth in the quarter of 0.7%. Stated net loss per share for the quarter was $(0.91) and adjusted earnings per share were $1.59, an enhance of 0.6% over the preceding year period.
“During the quarter, we accomplished our landmark combination to create Zimmer Biomet, marking a new era for our company and an unprecedented opportunity to drive our growth and value creation strategies,” said David Dvorak, President and CEO of Zimmer Biomet. “With a broad and diversified musculoskeletal portfolio, Zimmer Biomet is well positioned to reach new heights of commercial and operational excellence, and to accelerate the pace of our innovation for the evolving healthcare landscape.”
Zimmer Biomet Holdings, Inc., together with its auxiliaries, designs, develops, manufactures, and markets orthopaedic reconstructive devices, spinal and trauma devices, biologics, dental implants, and related surgical products in the Americas, Europe, and the Asia Pacific.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
